dosing cohorts

Related by string. dosing cohort * dosed . Dosing . Doser . doss . DOSS . Doss : Ann Doss Helms . convenient dosing regimen . optimal dosing regimen . By ERIN DOSS . dosing instructions . dosing interval / co horts . co hort . Cohorts . Cohort : Swedish Mammography Cohort . longitudinal cohort study . observational cohort study . observational cohort . retrospective cohort study . retrospective cohort * *

Related by context. Frequent words. (Click for all words.) 73 dose cohorts 69 mcg kg 68 evaluable patients 67 evaluable 67 Phase 2a trial 67 phase IIa 67 Phase 2b study 66 dose escalation 66 mg BID 66 dose regimens 66 dose limiting toxicities 66 Phase IIa trial 65 phase IIb 65 mg/m2 65 sustained virologic response 64 peginterferon alfa 2a 64 placebo controlled trials 64 plus methotrexate 64 Phase 1b 64 events SAEs 64 mg dose 64 FOLFOX 64 Phase Ib 64 Phase 2a 63 dosing regimens 63 vicriviroc 63 dose escalation trial 63 mg doses 63 blinded placebo controlled 63 JANUVIA 63 phase 2a 63 randomized #:# 63 peginterferon 63 unblinded 62 peginterferon alfa 2b 62 FOLFIRI 62 valopicitabine 62 Phase IIa clinical 62 plus ribavirin 62 Phase 1b clinical 62 LIALDA 62 Phase 2a clinical 62 RECIST criteria 62 Phase 2b trial 62 multicenter randomized double 62 sitagliptin 62 subcutaneous injections 61 pegylated interferon 61 interferon alfa 61 CRx 61 relapsed multiple myeloma 61 dasatinib 61 PROMACTA 61 elagolix 61 decitabine 61 events AEs 61 HCV genotype 1 61 HCV infected 61 HGS ETR1 61 TELCYTA 61 mitoxantrone 61 entecavir 61 liver metastases 61 NRTI 61 adalimumab 60 single ascending dose 60 mg m 60 median PFS 60 composite endpoint 60 raltegravir 60 multiple ascending dose 60 Phase III trials 60 ISENTRESS 60 Phase IIa 60 metastatic renal cell carcinoma 60 Phase IIb trial 60 Phase 2b clinical 60 placebo controlled 60 docetaxel 60 vinorelbine 60 azacitidine 60 Median survival 60 FOSRENOL R 60 dose escalation study 60 TMC# [001] 60 refractory multiple myeloma 60 CoFactor 60 Phase 2b 60 limiting toxicity 60 label dose escalation 60 randomized 59 double blind placebo 59 ONGLYZA 59 DSMB 59 tolerated dose MTD 59 bosentan 59 chronic HCV infection 59 blind randomized placebo 59 BAY #-# 59 teriparatide 59 abatacept

Back to home page